Entera Bio Ltd. - stock earnings
ENTX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -2.4 million USD | ? USD |
| 2023Q2 | -2.3 million USD | ? USD |
| 2023Q1 | 2.2 million USD | ? USD |
| 2022Q4 | -3.2 million USD | 14000 USD |
| 2022Q3 | -2.7 million USD | 8000 USD |
| 2022Q2 | -3.2 million USD | 44000 USD |
| 2022Q1 | -3.8 million USD | 68000 USD |
| 2021Q4 | 4.9 million USD | 165000 USD |
| 2021Q3 | -2.5 million USD | 140000 USD |
| 2021Q2 | -5.2 million USD | 109000 USD |
| 2021Q1 | -2.3 million USD | 157000 USD |
| 2020Q4 | -2.3 million USD | 221000 USD |
| 2020Q3 | -1.6 million USD | 50000 USD |
| 2020Q2 | -3.2 million USD | 52000 USD |
| 2020Q1 | -2.9 million USD | 42000 USD |
| 2019Q4 | -3.4 million USD | 102000 USD |
| 2019Q3 | -3.0 million USD | 60000 USD |
| 2019Q2 | -1.4 million USD | 74000 USD |
| 2019Q1 | -3.0 million USD | 500000 USD |
| 2018Q4 | -2.6 million USD | 500000 USD |
| 2018Q3 | -5.1 million USD | ? USD |
| 2018Q2 | 1.6 million USD | ? USD |
| 2018Q1 | -4.2 million USD | ? USD |
| 2017Q4 | -3.8 million USD | ? USD |
| 2017Q3 | -3.7 million USD | ? USD |
| 2017Q2 | -2.3 million USD | ? USD |
| 2017Q1 | -1.9 million USD | ? USD |
| 2016Q4 | -857000 USD | ? USD |
| 2016Q3 | -1.7 million USD | ? USD |
| 2016Q2 | -2.0 million USD | ? USD |
| 2015Q4 | -4.3 million USD | ? USD |
ENTX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -9.9 million USD | 14000 USD |
| 2022 | -13.1 million USD | 134000 USD |
| 2021 | -12.2 million USD | 571000 USD |
| 2020 | -10.0 million USD | 365000 USD |
| 2019 | -10.9 million USD | 236000 USD |
| 2018 | -10.3 million USD | 500000 USD |
| 2017 | -11.2 million USD | ? USD |
| 2016 | -1.2 million USD | ? USD |
| 2015 | -4.3 million USD | ? USD |
ENTX
Price: $2.09
52 week price:
Earnings Per Share: -0.31 USD
P/E Ratio: -2.65
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 1891
Market Capitalization: 79.8 million